<DOC>
	<DOC>NCT01500499</DOC>
	<brief_summary>RATIONALE: Studying samples of blood, tissue, and bone marrow from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research trial studies the role of biomarkers in disease progression in samples from patients with acute myeloid leukemia.</brief_summary>
	<brief_title>Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia</brief_title>
	<detailed_description>OBJECTIVES: - To determine the subcellular localization of the MLL-AF1q fusion protein in leukemia cells. OUTLINE: Cryopreserved specimens are analyzed for MLL-AF1q fusion protein and AF1 gene expression by mass spectrometry, western blot analysis, semi-quantitative PCR, and qPCR.</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia, Myeloid</mesh_term>
	<mesh_term>Leukemia, Myeloid, Acute</mesh_term>
	<criteria>DISEASE CHARACTERISTICS: Cryopreserved acute myeloid leukemia specimens PATIENT CHARACTERISTICS: Not specified PRIOR CONCURRENT THERAPY: Not specified</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>adult acute myeloid leukemia</keyword>
	<keyword>childhood acute myeloid leukemia/other myeloid malignancies</keyword>
</DOC>